Home › Funds › New Vernon Capital Holdings II LLC › PTCT
New Vernon Capital Holdings II LLC position in PTCT
PTC THERAPEUTICS INC · Health Care
New Vernon Capital Holdings II LLC reported holding 3,668 shares of PTCT (PTC THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$299K, representing 0.16% of its reported portfolio and ranking #32 among its reported holdings. New Vernon Capital Holdings II LLC has disclosed PTCT holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How New Vernon Capital Holdings II LLC's PTCT position evolved
New Vernon Capital Holdings II LLC first disclosed a stake in PTCT in Q3 2025 at 3,675 shares (US$226K). The position peaked in Q2 2026 at 3,668 shares, worth US$299K. Across 4 filings, New Vernon Capital Holdings II LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 3,668 shares valued at US$299K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 3.67K | $225.53K | New |
| Q4 2025 | 3.67K | $278.62K | Hold |
| Q1 2026 | 3.67K | $249.90K | Hold |
| Q2 2026 | 3.67K | $299.20K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PTCT and 13F data
PTCT (PTC THERAPEUTICS INC) is a Health Care company. 55 other funds we track also report a position in PTCT — the largest reported positions include RTW INVESTMENTS, LP (US$631.9M), TORONTO DOMINION BANK (US$176.7M), WESTFIELD CAPITAL MANAGEMENT CO LP (US$159.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PTCT
- RTW INVESTMENTS, LP 7.75M sh · $631.88M · Q2 2026
- TORONTO DOMINION BANK 2.17M sh · $176.67M · Q2 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 1.96M sh · $159.56M · Q2 2026
- Hood River Capital Management LLC 1.74M sh · $141.82M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 1.50M sh · $122.36M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 1.44M sh · $117.47M · Q2 2026
- Jefferies Financial Group Inc. 1.36M sh · $110.69M · Q2 2026
- Blue Sparrow, LLC /DE 1.05M sh · $85.71M · Q2 2026
- Palo Alto Investors LP 918.85K sh · $74.95M · Q2 2026
- ARMISTICE CAPITAL, LLC 660.00K sh · $53.84M · Q2 2026
- Parkman Healthcare Partners LLC 435.69K sh · $35.54M · Q2 2026
- Defilade Capital Management, L.P. 433.70K sh · $35.38M · Q2 2026
More on New Vernon Capital Holdings II LLC
FAQ
How long has New Vernon Capital Holdings II LLC held PTCT?
New Vernon Capital Holdings II LLC has disclosed PTCT holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is New Vernon Capital Holdings II LLC's current position in PTCT?
As of Q2 2026, New Vernon Capital Holdings II LLC holds 3.67K shares of PTCT (PTC THERAPEUTICS INC), valued at $299.20K, representing 0.16% of its reported portfolio and ranking #32.
Has New Vernon Capital Holdings II LLC been buying or selling PTCT?
In the latest 13F filing (Q2 2026), New Vernon Capital Holdings II LLC held unchanged its position in PTCT. The position peaked in Q2 2026 at 3.67K shares.
Which other funds hold PTCT?
Other major institutional holders of PTCT include RTW INVESTMENTS, LP, TORONTO DOMINION BANK, WESTFIELD CAPITAL MANAGEMENT CO LP, among 55 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.